Inhaled corticosteroids and the risks of diabetes onset and progression

American Journal of Medicine

Volumn 123, Issue 11, 2010, Pages 1001-1006

  Suissa, Samy ^a,b   Kezouh, Abbas ^a   Ernst, Pierre ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Drug safety; Glucocorticoids; Observational studies

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; INSULIN; METFORMIN; SULFONYLUREA; TRIAMCINOLONE;

ADULT; ARTICLE; ASTHMA; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA BASE; DIABETES MELLITUS; DISEASE EXACERBATION; DOSE RESPONSE; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; DIABETES MELLITUS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; RESPIRATORY TRACT DISEASES; RISK FACTORS;

EID: 78049430514     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.06.019     Document Type: Article

References (24)

1. D.S. Postma, and P. Calverley Inhaled corticosteroids in COPD: a case in favour Eur Respir J 34 2009 10 12
2. S. Suissa, and P.J. Barnes Inhaled corticosteroids in COPD: the case against Eur Respir J 34 2009 13 16
3. K.F. Rabe, S. Hurd, and A. Anzueto Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
4. P.M. Calverley, J.A. Anderson, and B. Celli Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
5. J.A. Wedzicha, P.M. Calverley, T.A. Seemungal, G. Hagan, Z. Ansari, and R.A. Stockley The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide Am J Respir Crit Care Med 177 2008 19 26
6. E. Garbe, J. LeLorier, J.F. Boivin, and S. Suissa Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma JAMA 277 1997 722 727
7. E. Garbe, S. Suissa, and J. LeLorier Association of inhaled corticosteroid use with cataract extraction in elderly patients [published erratum appears in JAMA. 1998;280(21):1830] [see comments] JAMA 280 1998 539 543
8. B.J. Lipworth Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis Arch Intern Med 159 9 1999 941 955
9. H.W. Kelly, and H.S. Nelson Potential adverse effects of the inhaled corticosteroids J Allergy Clin Immunol 112 2003 469 478
10. P. Ernst, A.V. Gonzalez, P. Brassard, and S. Suissa Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia Am J Respir Crit Care Med 176 2007 162 166
11. K.R. Chapman, D.M. Mannino, and J.B. Soriano Epidemiology and costs of chronic obstructive pulmonary disease Eur Respir J 27 2006 188 207
12. Y. Lacasse, D. Brooks, and R.S. Goldstein Trends in the epidemiology of COPD in Canada, 1980 to 1995 COPD and Rehabilitation Committee of the Canadian Thoracic Society Chest 116 1999 306 313
13. D. Yach, C. Hawkes, C.L. Gould, and K.J. Hofman The global burden of chronic diseases: overcoming impediments to prevention and control JAMA 291 2004 2616 2622
14. D.M. Mannino, D. Thorn, A. Swensen, and F. Holguin Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur Respir J 32 2008 962 969
15. J.S. Rana, M.A. Mittleman, and J. Sheikh Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women Diabetes Care 27 2004 2478 2484
16. P. Kardos, M. Wencker, T. Glaab, and C. Vogelmeier Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 2007 144 149
17. N. Dendukuri, L. Blais, and J. LeLorier Inhaled corticosteroids and the risk of diabetes among the elderly Br J Clin Pharmacol 54 1 2002 59 64
18. D. Blackburn, J. Hux, and M. Mamdani Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly J Gen Intern Med 17 2002 717 720
19. C.G. Slatore, C.L. Bryson, and D.H. Au The association of inhaled corticosteroid use with serum glucose concentration in a large cohort Am J Med 122 2009 472 478
20. M.C. Breton, J. LeLorier, A. Forget, and L. Blais Use of combination therapy in asthma: are they prescribed according to guidelines Respir Med 101 2007 1916 1923
21. P. Ernst, M. Baltzan, J. Deschenes, and S. Suissa Low-dose inhaled and nasal corticosteroid use and the risk of cataracts Eur Respir J 27 2006 1168 1174
22. S. Suissa, M. Baltzan, R. Kremer, and P. Ernst Inhaled and nasal corticosteroid use and the risk of fracture Am J Respir Crit Care Med 169 2004 83 88
23. M.J. Akerman, C.M. Calacanis, and M.K. Madsen Relationship between asthma severity and obesity J Asthma 41 2004 521 526
24. B.R. Celli, C.G. Cote, and J.M. Marin The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012